HealthFlex
×
  • About Us
    • Company Management
    • Meet Our Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Careers
  • Technologies
    • Oncoprex® Delivery System
    • Reqorsa® Gene Therapy
    • GPX-002
  • Programs
    • Oncology
    • Diabetes
  • Clinical Trials
    • Pipeline
    • ONC-001
    • ONC-002
    • Acclaim-1
    • Acclaim-3
    • DIA-001 and DIA-002
    • Expanded Access Policy
  • Investors
    • Company Profile
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder FAQ
    • Downloads
    • Events
  • News
    • Press Releases
    • Blog Posts
    • Media Coverage
    • Videos
  • Contact
Celina Laney

Celina Laney

Chief of Staff

Celina Laney joined Genprex in June 2018 and serves as the company’s Chief of Staff. In this role, she partners closely with executive leadership to drive organizational effectiveness by streamlining administrative procedures, strengthening internal controls, and overseeing day-to-day office operations.

Celina plays a central role in coordinating across all departments, including HR, finance, IT, clinical, manufacturing, and quality. She also manages relationships with external vendors and service providers, supporting efficient, compliant, and cost-effective operations across the organization.

Her responsibilities include executive and board support, vendor and contract management, accounting and payroll coordination, software and licensing oversight, and communication with regulatory agencies. With her institutional knowledge and cross-functional leadership skills, Celina serves as a key operational and strategic resource for the company.

Prior to joining Genprex, Celina served as Executive Assistant to the company’s former CEO  beginning in 2010. She brings more than 18 years of experience in legal secretary and litigation assistant roles with law firms in Austin and Houston, where she supported complex litigation matters through legal research, court filings and trials, scheduling, and client communications.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

(877) 774-GNPX (4679)

3300 Bee Cave Road, Suite 650-227 Austin, TX 78746

Quick Links

  • About Us
  • Clinical Trials
  • Investors
  • Downloads
  • Press Releases
  • X
  • Facebook
  • LinkedIn

Latest News

  • Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer Apr 30
  • Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting Apr 28
  • Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting Apr 22
  • Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy Apr 21
Designed and Secured by Barsec
Copyright ©2026 all rights reserved.
Home - Privacy Policy - Terms of Use